Interestingly, in Alzheimer's disease research, a similar observation was noted where the chronic treatment with sorafenib inhibited c-Raf and NF-κB in the brains of the aged APPswe mice [44]. Here, RAF1 is linked to early-onset autosomal dominant Alzheimer disease.